Pharmafile Logo
Pharmafocus logo
Advanced Search

EU

Showing 15 posts of 252 posts found.

AstraZeneca licenses European rights to constipation drug for $70m

March 1, 2016
Manufacturing and Production, Sales and Marketing AstraZeneca, EU, Japan, Luke Miles, ProStrakan Group, constipation drug, moventig

AstraZeneca said on Tuesday it has agreed to licence rights to its constipation drug Moventig to Japan’s ProStrakan Group for …

News
CEP report

Pharma ‘spends €40m to sway EU politicians’

September 2, 2015
Medical Communications EU, European Commission, TTIP, drug policy, lobbying, transparency

The pharma industry has excessive power over EU decision-makers and spends €40 million a year to influence EU drug policy, …

News

EU approval for new Sanofi, Merck vaccine

June 18, 2015
Sales and Marketing EU, Europe, Merck, Sanofi, Sanofi pasteur msd, brett wells, gardasil 9

Sanofi and Merck are looking forward to a successor to their blockbuster Gardasil now that the European Commission has granted …

News
Abbvie image

AbbVie hep C drug gets priority review in Japan

April 16, 2015
Sales and Marketing AbbVie, EC, EU, Europe, Exviera, FDA, Japan, Viekira Pak, Viekirax, hepatitis C, ombitasvir/paritaprevir/ritonavir

AbbVie’s combination hepatitis C treatment looks set to be approved in yet another country after being granted priority review in …

News

World Health Organisation calls for full trial transparency

April 14, 2015
Research and Development, Sales and Marketing Ben Goldacre, EU, WHO, World Health Organisation, alltrials, clinical trials, sense about science, transparency

The World Health Organization has thrown its weight behind clinical trial transparency in a new statement on its position. WHO …

News
Saxenda image

Novo Nordisk obesity drug gets EU approval

March 24, 2015
Sales and Marketing EMA, EU, FDA, Victoza, liraglutide, obesity, saxenda

Novo Nordisk’s obesity drug Saxenda has been approved by the European Commission for use across the EU. This approval follows …

News
Jakavi image

Novartis blood cancer drug given EU nod

March 17, 2015
Sales and Marketing Cancer, EU, Jakavi, Novartis, oncology, polycythemia vera, ruxolitinib

Novartis’ blood cancer drug Jakavi has been given the green light in Europe to treat adult patients with polycythemia vera …

News
Novartis image

Novartis earns EMA and FDA nods for Jakavi and Bexsero

January 26, 2015
Sales and Marketing Bexsero, Cancer, EU, FDA, Jakavi, Novartis, US, meningitis, ruxolitinib

Novartis has secured the regulatory go-ahead for two of its drugs, after the EMA recommended Jakavi for a rare blood …

News
EMA image

EMA launches consultation on clinical trials

January 22, 2015
Research and Development, Sales and Marketing EFPIA, EMA, EU, Europe, Goldacre, alltrials, transparency

The European Medicines Agency has invited pharma to comment on its proposals to ramp up transparency in the industry and …

News
GSK image

GSK Ebola vaccine gets EU support

December 17, 2014
Research and Development, Sales and Marketing EC, EU, Ebola, Europe, GSK, Merck, Takeda, Vaccine, WHO, johnson

A newly-formed European consortium is to help advance the development of GlaxoSmithKline’s promising Ebola vaccine. The consortium is backed by …

News
BI image

Boehringer’s lung cancer drug Vargatef sees EU approval

November 28, 2014
Sales and Marketing Boehringer, EU, Europe, IPF, NSCLC, lung cancer, nintedanib, ofev, vargatef

Boehringer Ingelheim’s nintedanib has received its second nod in Europe this month with the European Commission approving it for the …

News
Harvoni image

Gilead gets Harvoni boost for Europe

November 20, 2014
Sales and Marketing EU, Gilead, HCV, harvoni, hepc, ledipasvir, sofosbuvir, svaldi

Gilead Sciences’ new hepatitis C (HCV) tablet Harvoni has been approved across the European Union to treat the majority of …

News
Rasi image

EMA in turmoil as top job ‘annulled’

November 17, 2014
Sales and Marketing EC, EMA, EU, Europe, Guido Rasi, Rasi, transparency

The future of Guido Rasi, head of Europe’s drugs regulator, is up in the air after a legal ruling which …

News

Scenesse recommended for rare sun disease in Europe

October 27, 2014
Sales and Marketing CHMP, Clinuvel Pharmaceuticals, EMA, EU, scenesse

The European Medicines Agency is recommending that Scenesse (afamelanotide) be approved for the prevention of severe sun burn in adults …

News

Sovaldi combo sees CHMP green light

September 29, 2014
Sales and Marketing CHMP, EU, Gilead, HCV, harvoni, hep C, sovaldi

The CHMP is recommending that Gilead’s new combination hepatitis C drug therapy Harvoni should be approved for use across the …

News
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026